Skip to content

Author

F. Fogacci

We have 2 of 276 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Lifestyle strategies and nutraceuticals in chronic venous disease: an evidence-weighted synthesis and clinical positioning.

A phenotype-stratified approach should prioritise weight control and compression as core interventions, with targeted nutraceuticals considered according to dominant clinical goals: symptom relief, quality of life, oedema control, or ulcer healing.

F. Fogacci, Valentina Di Micoli, A. Avagimyan et al. · 0 citations
Review Open access Aug 2026

Triglyceride–glucose index as a cardiovascular risk marker: updated evidence, limitations, and future perspectives

While current evidence supports its association with incident CVD, atherosclerotic burden, and adverse outcomes, further prospective, multiethnic studies are needed to define optimal thresholds, clarify its role alongside existing risk models, and determine whether TyG-guided strategies can improve clinical outcomes.

M. Cherska, Khrystyna Kukharchuk, A. Ceasovschih et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.